Background The impact of disease-modifying therapies on the efficacy to mount appropriate
immune responses to COVID-19 vaccination in patients with multiple sclerosis (MS) is …

Purpose Detection and prediction of the rate of brain volume loss with age is a significant
unmet need in patients with primary progressive multiple sclerosis (PPMS). In this study we …

… Zohar Shmuelian and Yehuda Warszawer contributed equally to this report. … Analysis
and interpretation of results: Yehuda Warszawer, Zohar Shmuelian, Giovanna Jona-Lasinio, …

Background Relapsing-remitting multiple sclerosis (RRMS) affects predominantly young
women within reproductive years. As an increased risk of relapses is known to occur during the …

Background During the COVID-19 pandemic, post-exposure-prophylaxis is not a practice.
Following exposure, only patient isolation is imposed. Moreover, no therapeutic prevention …

During the COVID-19 pandemic, post-exposure-vaccine-prophylaxis is not a practice.
Following exposure, only patient isolation is imposed. Moreover, no therapeutic prevention …

In both children and adults, magnetic resonance imaging of the brain in cases of multiple
sclerosis (MS) has typical indications, where one of the key points for differentiating between …

Background: During the COVID-19 pandemic, post-exposure-prophylaxis is not a practice.
Following exposure, only patient isolation is imposed. Moreover, no therapeutic prevention …

A 74-year-old right-handed male presented with headaches, paroxysmal cervical pain and
gait instability that worsened during exercise walking. Neurological examination …

Objective: To determine the immunocompetency of patients with multiple sclerosis treated
with the lymphodepleting humanized monoclonal antibody alemtuzumab. Methods: In this …